1. Home
  2. COCP vs CREG Comparison

COCP vs CREG Comparison

Compare COCP & CREG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • CREG
  • Stock Information
  • Founded
  • COCP 2006
  • CREG N/A
  • Country
  • COCP United States
  • CREG China
  • Employees
  • COCP N/A
  • CREG N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • CREG Power Generation
  • Sector
  • COCP Health Care
  • CREG Utilities
  • Exchange
  • COCP Nasdaq
  • CREG Nasdaq
  • Market Cap
  • COCP 15.7M
  • CREG 16.6M
  • IPO Year
  • COCP N/A
  • CREG N/A
  • Fundamental
  • Price
  • COCP $1.49
  • CREG $0.22
  • Analyst Decision
  • COCP Strong Buy
  • CREG
  • Analyst Count
  • COCP 1
  • CREG 0
  • Target Price
  • COCP $6.00
  • CREG N/A
  • AVG Volume (30 Days)
  • COCP 26.0K
  • CREG 4.6M
  • Earning Date
  • COCP 08-13-2025
  • CREG 08-13-2025
  • Dividend Yield
  • COCP N/A
  • CREG N/A
  • EPS Growth
  • COCP N/A
  • CREG N/A
  • EPS
  • COCP N/A
  • CREG N/A
  • Revenue
  • COCP N/A
  • CREG $20,625.00
  • Revenue This Year
  • COCP N/A
  • CREG N/A
  • Revenue Next Year
  • COCP N/A
  • CREG N/A
  • P/E Ratio
  • COCP N/A
  • CREG N/A
  • Revenue Growth
  • COCP N/A
  • CREG N/A
  • 52 Week Low
  • COCP $1.12
  • CREG $0.20
  • 52 Week High
  • COCP $3.26
  • CREG $1.47
  • Technical
  • Relative Strength Index (RSI)
  • COCP 45.80
  • CREG 23.89
  • Support Level
  • COCP $1.48
  • CREG $0.20
  • Resistance Level
  • COCP $1.58
  • CREG $1.47
  • Average True Range (ATR)
  • COCP 0.10
  • CREG 0.13
  • MACD
  • COCP -0.01
  • CREG -0.03
  • Stochastic Oscillator
  • COCP 15.38
  • CREG 1.77

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About CREG Smart Powerr Corp.

Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company offers waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.

Share on Social Networks: